Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-026965
Filing Date
2025-08-14
Accepted
2025-08-14 16:31:14
Documents
47
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20250630_10q.htm   iXBRL 10-Q 942600
2 EXHIBIT 31.1 ex_820908.htm EX-31.1 16154
3 EXHIBIT 31.2 ex_820909.htm EX-31.2 14651
4 EXHIBIT 32.1 ex_820910.htm EX-32.1 8382
  Complete submission text file 0001437749-25-026965.txt   4843509

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20250630.xsd EX-101.SCH 43422
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20250630_cal.xml EX-101.CAL 18402
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20250630_def.xml EX-101.DEF 296720
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20250630_lab.xml EX-101.LAB 283216
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20250630_pre.xml EX-101.PRE 318328
50 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20250630_10q_htm.xml XML 700226
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 251219938
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)